Your browser doesn't support javascript.
loading
Quality Control of Intravenous Infusion Product of Antitumor Drugs in PIVAS of Our Hospital / 中国药房
China Pharmacy ; (12): 3532-3534, 2016.
Article in Zh | WPRIM | ID: wpr-504956
Responsible library: WPRO
ABSTRACT

OBJECTIVE:

To effectively control the quality of intravenous infusion product of antitumor drugs in PIVAS,and to guarantee the safety of clinical drug use.

METHODS:

According to the operation flow of intravenous infusion product,the quality control of anti-tumor drugs was conducted in PIVAS of our hospital from three aspects,i.e. before,during and after admixture. The improvement effect was compared before and after the implementation.

RESULTS:

Pre-admixture management was carried out through special classification management and medical order check management for antitumor drug;intra-admixture management was carried out through the management of admixture environment,solvent selection,admixture method,order for adding drug, dosage;post-admixture management was carried out through standard examination of infusion product and the management of deliv-ery time and condition. 5 months later,the times of communication between PIVAS and clinical departments was decreased from 30 times to 10 times,and the incidence of infusion product was decreased from 0.68% to 0.18%.

CONCLUSIONS:

Standard man-agement has been conducted for operation procedure of anti-tumor drugs before,during and after admixture. The quality of intrave-nous infusion product of antitumor drugs can be effectively controlled to ensure the safety of clinical drug use.
Key words
Full text: 1 Index: WPRIM Language: Zh Journal: China Pharmacy Year: 2016 Type: Article
Full text: 1 Index: WPRIM Language: Zh Journal: China Pharmacy Year: 2016 Type: Article